Archives
-
Y-27632 Dihydrochloride: ROCK1–PD-L1 Insight
2026-08-15
Y-27632 dihydrochloride is a selective ROCK inhibitor that can do more than alter cell shape. This article shows how to use it as a causal probe for the DR5–ROCK1–PD-L1 axis while separating cytoskeletal, viability, invasion, and immune-evasion readouts.
-
Carbapenemase Transmission in CREC, 2022–2024
2026-08-14
Chen et al. provide an integrated analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. By combining gene localization, antimicrobial susceptibility testing, conjugation, mobile-element profiling, and strain typing, the study clarifies how blaNDM−1-dominated resistance can disseminate through both plasmid-mediated transfer and clonal spread.
-
CSBTA Pharmacokinetics in MASH Mice
2026-08-14
The reference study shows that MASH-like pathology substantially alters the exposure, liver distribution, and hepatocyte accumulation of dehydrocavidine, palmatine, and berberine from Corydalis saxicola Bunting total alkaloids. By integrating UHPLC-MS/MS profiling with transporter, microsomal metabolism, and PXR-related experiments, it links disease-associated pharmacokinetic variability to coordinated changes in CYP450 enzymes and drug transporters.
-
KDM3A–METTL16–PDK1 Axis in TKI Resistance
2026-08-13
The reference study identifies a coordinated epigenetic and RNA-modification pathway that elevates PDK1 and drives EGFR-TKI resistance and tumor progression. Its findings connect KDM3A-mediated histone demethylation with METTL16–IGF2BP1-dependent PDK1 mRNA stabilization, providing a mechanistic framework for biomarker development and combination treatment strategies.
-
Gepotidacin: Mechanism, Evidence & Research Use
2026-08-13
Gepotidacin, also known as GSK2140944, is a first-in-class bacterial type II topoisomerase inhibitor that targets DNA gyrase and topoisomerase IV through a distinct binding mode. Biochemical, microbiological, and phase 2 data support its use as a research tool for bacterial DNA replication inhibition and antibiotic resistance research, while clinical-scope and assay-specific limits remain important.
-
Abiraterone acetate in 3D Prostate Models
2026-08-12
Use Abiraterone acetate as a mechanistically grounded CYP17 inhibitor in patient-derived prostate spheroids, where three-dimensional architecture can expose treatment-response patterns missed by monolayers. This guide combines solvent handling, dose-response design, orthogonal readouts, and troubleshooting for translational prostate cancer research.
-
DiscoveryProbe Protease Inhibitor Library: Assay Design
2026-08-12
The DiscoveryProbe Protease Inhibitor Library is more than a compound set: it can be used as a decision framework for protease inhibition, orthogonal validation, and pathway-level discovery. This article translates lessons from commercial virtual-screening libraries into practical biochemical, cellular, and high-content assay strategies.
-
IPA-3 for Reliable Pak1 Cell Assays
2026-08-11
Learn how IPA-3 (SKU B2169), a non-ATP-competitive Pak1 pathway inhibitor, can be incorporated into cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers mechanism, solvent compatibility, concentration planning, interpretation limits, and practical supplier selection.
-
Azilsartan medoxomil monopotassium Workflows
2026-08-11
Build more reproducible AT1-receptor, cellular signaling, and preclinical blood-pressure experiments with Azilsartan medoxomil monopotassium, also known as TAK 491. This guide connects concentration control, washout design, and comparative efficacy testing to clinically relevant hypertension research while addressing solubility and assay-variability risks.
-
3X FLAG peptide Workflow Guide
2026-08-10
Turn a compact 3X FLAG handle into a practical system for affinity purification, sensitive immunodetection, and structural biology. This guide explains competitive elution, metal-sensitive assay design, crystallization preparation, and troubleshooting for low signal or poor recovery.
-
AAPH Oxidation of Hazelnut Protein Gels
2026-08-09
Jiang et al. compared AAPH-, malondialdehyde-, and hydrogen peroxide-mediated oxidation to show that oxidation chemistry, rather than oxidation intensity alone, determines hazelnut protein functionality and gel structure. The study identifies distinct changes in water binding, emulsification, foaming, and gel-network morphology, providing a useful framework for designing protein oxidation and food-structure experiments.
-
Vincristine Sulfate: Mechanism to Translation
2026-08-08
Vincristine sulfate is more than a cytotoxic control: it is a mechanistically defined probe of microtubule dynamics whose value depends on connecting target engagement, phenotype, exposure, and disease context. This thought-leadership guide shows translational researchers how to design more reproducible studies while recognizing the boundaries between product evidence, experimental validation, and clinical relevance.
-
Amikacin Disulfate Workflows for Antibiotic Research
2026-08-07
Build reproducible workflows for ribosome-focused antibiotic mechanism studies, bacterial growth assays, and protein–drug interaction analysis. This guide connects practical handling of amikacin disulfate with fluorescence, binding, and resistance-research strategies inspired by recent multimodal work.
-
Hydrocortisone in Neural Signaling: Rapid Modulation and Res
2026-08-07
Explore hydrocortisone’s rapid modulation of neuronal calcium signaling as a glucocorticoid hormone, revealing novel mechanisms essential for advanced neuroscience and inflammation model research. This article uniquely dissects nongenomic pathways, experimental best practices, and the latest findings for precision assay design.
-
Reserpine (N1867): Technical Guidance for Laboratory Researc
2026-08-06
Reserpine (SKU N1867) is a high-purity standard for neurotransmitter depletion and antihypertensive mechanism studies in controlled laboratory research. This compound provides precise, reproducible results when handled according to established solubility and storage protocols. It is not intended for diagnostic, clinical, or veterinary applications.